No abstract available
MeSH terms
-
Animals
-
Diabetes Mellitus, Type 2 / drug therapy
-
Exenatide
-
Gastric Bypass / adverse effects*
-
Glucagon-Like Peptide 1 / adverse effects*
-
Humans
-
Hyperinsulinism / etiology*
-
Hypoglycemia / etiology*
-
Insulin-Secreting Cells / drug effects
-
Nesidioblastosis / etiology*
-
Peptides / adverse effects*
-
Peptides / therapeutic use
-
Postoperative Complications
-
Venoms / adverse effects*
-
Venoms / therapeutic use
Substances
-
Peptides
-
Venoms
-
Glucagon-Like Peptide 1
-
Exenatide